Sterilray launches Zoonotic Tech for livestock disease prevention

2 hours ago

Sterilray has formed Zoonotic Tech, Inc. to focus on continuous livestock disinfection and monitoring tools aimed at reducing zoonotic disease transmission, starting with H5N1 threats to poultry, swine and cattle. The push centers on 222 nm Far-UV technology and related research trials designed to validate faster, non-chemical outbreak prevention on farms. Why it matters: - Zoonotic disease outbreaks can spread quickly through livestock operations and trigger major economic losses. - Sterilray is positioning continuous disinfection and monitoring as an alternative to mass culling and broad inoculation efforts. - The initial focus on H5N1 reflects growing pressure on poultry, swine and cattle producers in the U.S. and worldwide. What happened: - Sterilray announced the formation of Zoonotic Tech, Inc. to target pathogens associated with zoonotic disease transmission. - The first deployment effort will focus on mitigating H5N1. - Mike Olsen, Sterilray CEO, said the company formed Zoonotic Tech to assemble management and capital partners for rapid-deployment trials. - Sterilray is inviting livestock farmers, agricultural organizations and research universities to join university-supervised trials. The details: - Sterilray says its 222 nm Far-UV technology has already been demonstrated on pig farms, where it reduced viral transmission and helped prevent livestock losses. - The company says Far-UV 222 nm is different from traditional UV-C because it is designed to be safe for humans and animals while neutralizing viral pathogens, bacteria and mold. - Zoonotic Tech is also investing in clinical research on Far-UV for aerosolized disinfection. - The company plans to evaluate other technologies that may perform as well or better against different transmission vectors. - Zoonotic Tech intends to layer multiple protections together, including continuous monitoring of the livestock environment. - Testing and deployment are ready to begin immediately. - Sterilray describes itself as a global leader in 222 nm Far-UV disinfection technology. - Sterilray says its commercial devices use patented 222 nm Sterilray technology and have been deployed globally since 2007. - The company says its Far UV lamps are powerful, chemical-free and environmentally friendly. Between the lines: - The launch signals a broader commercialization push beyond disinfection hardware into a farm-biosecurity platform built around prevention, research and monitoring. - The reference to multiple technologies suggests Sterilray is trying to create a layered defense model rather than rely on a single tool. - The trial-first approach indicates the company still needs field validation before wider adoption. What’s next: - Zoonotic Tech will pursue university-supervised trials with industry partners. - The company will continue clinical research on aerosolized disinfection and other transmission-control methods. - Sterilray expects rapid-deployment testing to help validate the approach and speed adoption. - Further expansion will likely depend on whether the technology proves effective across different farm environments and disease pathways.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.